No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SGHT240517C5000
- 0.45
- -0.15-25.00%
15min DelayClose May 13 15:55 ET
0.45High0.45Low
0.45Open0.60Pre Close1 Volume43 Open Interest5.00Strike Price45.00Turnover74.14%IV0.55%PremiumMay 17, 2024Expiry Date0.42Intrinsic Value100Multiplier3DDays to Expiry0.03Time Value100Contract SizeAmericanOptions Type0.8696Delta0.5238Gamma12.04Leverage Ratio-0.0120Theta0.0004Rho10.47Eff Leverage0.0012Vega
Intraday
- 5D
- 1D
News
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing
Sight Sciences | 10-Q: Quarterly report
Sight Sciences, Inc. (NASDAQ:SGHT) Analysts Are Pretty Bullish On The Stock After Recent Results
Shareholders of Sight Sciences, Inc. (NASDAQ:SGHT) will be pleased this week, given that the stock price is up 13% to US$5.96 following its latest first-quarter results. Revenue of US$19m came i
Earnings Call Summary | Sight Sciences(SGHT.US) Q1 2024 Earnings Conference
The following is a summary of the Sight Sciences, Inc. (SGHT) Q1 2024 Earnings Call Transcript:Financial Performance:Sight Sciences reported Q1 2024 revenue of $19.3 million, a record for their first
Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed
Sight Sciences (SGHT) shares were up nearly 4%, a day after the company reported narrower Q1 loss and revenue that exceeded consensus. The company reported Q1 net loss Thursday of $0.33 per diluted sh
Comments
$Sight Sciences(SGHT.US$
NEWS
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
NEWS
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT) announces results of a large-scale MIGS study comparing three leading technologies in glaucoma patients. OMNI technology shows significant IOP and...
Revolutionizing Glaucoma and Dry Eye Treatment: Insights from Sight Sciences' Groundbreaking Clinical Trials.
In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
In the realm of ophthalmology, groundbreaking advancements are not just welcomed; they are necessary. As we navigate through the complexities of eye diseases, companies like Sight Sciences are leading the charge with innovative solutions that promise not only relief but also a renewed hope for millions globally. Rec...
Sight Sciences' high P/S ratio may be precarious given forecasted revenue declines, posing the risk of a future drop in share prices despite recent gains.
$Sight Sciences(SGHT.US$ crazy day, what is going on?!
Post downgrade, analysts are skeptical about Sight Sciences' value. 2024 revenue drop hints at measured investor expectations. Due to recent business events, a slashed price target may steer investors towards caution.
Read more